We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Genentech Dissatisfied with Roche Buyout Offer

By LabMedica International staff writers
Posted on 20 Aug 2008
The special committee of Genentech, formed to consider Roche's offer to buy all of Genentech's outstanding, shares expressed its dissatisfaction with the tender first made in July 2008.

The committee turned down Roche's US$43.7 billion bid, stating that the offer substantially undervalues the company, but added that they would consider a proposal that recognizes the true value of Genentech as well as the benefits that Roche would realize resulting from full ownership of the biotech pioneer. More...


Dr. Charles A. Sanders, chairman of the special committee, said, "The special committee is confident in the company's strong financial and clinical momentum and its uniquely productive R&D capabilities, which will continue to enhance shareholder value. In addition, we look forward to the company maintaining its successful relationship with Roche, regardless of ownership structure."

Roche, already the owner of nearly 56% of Genetech, is likely to move quickly to seal the deal. Analysts expect that Roche may end up paying around 20% premium over the initial offer of about $89 per share of Genentech.

Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with significant unmet medical needs. The company with over 100 projects in development is headquartered in South San Francisco, CA, USA, and had total operating revenues of $11.7 billion in 2007.

Related Links:
Hoffman-La Roche
Genentech


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Automated Immunoassay Analyzer
SuperFlex™
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.